| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |